AN INTERVENTIONAL PHASE 1B/2, OPEN-LABEL STUDY TO INVESTIGATE THE SAFETY, ANTITUMOR ACTIVITY, AND PHARMACOKINETICS OF PF 08634404 MONOTHERAPY OR IN COMBINATION WITH ENFORTUMAB VEDOTIN IN ADULT PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER
AN INTERVENTIONAL PHASE 1B/2, OPEN-LABEL STUDY TO INVESTIGATE THE SAFETY, ANTITUMOR ACTIVITY, AND PHARMACOKINETICS OF PF 08634404 MONOTHERAPY OR IN COMBINATION WITH ENFORTUMAB VEDOTIN IN ADULT PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER
This study is being done to learn more about a new medicine called PF-08634404. It is for adults with a type of bladder cancer called locally advanced or metastatic urothelial cancer (LA/mUC), meaning the cancer has spread to nearby tissues or other parts of the body.
The purpose of the study is to see if PF-08634404 is safe, how well it works, how it moves through the body, and how it affects the cancer. The study will also look at how the medicine may change certain markers in the body that are linked to cancer.
To join the study, participants must:
The study has two groups:
Everyone in the study will get the study medicine through a vein (IV infusion) with or without enfortumab vedotin. Treatment will continue as long as it helps and side effects are manageable.
Before starting, participants will go through a screening period to check if they are eligible. During the study, they will have regular visits for treatment, health checks, and tests to see how the cancer is responding. Scans will be done regularly to monitor the cancer.
If the cancer gets worse but the treatment is still helping and side effects are manageable, participants may be allowed to continue treatment with their doctor's and the sponsor's agreement.
Inclusion Criteria:
Exclusion Criteria:
Participants will be excluded if they meet any of the following:
ClinicalTrials.gov_Inquiries@pfizer.com1-800-718-1021
Beverly Hills, California 90212, United States
Duarte, California 91010, United States
La Jolla, California 92037, United States
Laguna Hills, California 92653, United States
Los Angeles, California 90095, United States
Marina del Rey, California 90292, United States
Porter Ranch, California 91326, United States
San Diego, California 92103, United States
San Luis Obispo, California 93401, United States
Santa Barbara, California 93101, United States
Santa Monica, California 90404, United States
Westlake Village, California 91361, United States
Norwich, Connecticut 06360, United States
Washington D.C., District of Columbia 20016, United States
Baltimore, Maryland 21231, United States
Baltimore, Maryland 21231, United States
Baltimore, Maryland 21287, United States
St Louis, Missouri 63110, United States
Durham, North Carolina 27710, United States
Durham, North Carolina 27710, United States
Raleigh, North Carolina 27609, United States
Chattanooga, Tennessee 37403, United States
Chattanooga, Tennessee 37404, United States
Chattanooga, Tennessee 37404, United States
Chattanooga, Tennessee 37404, United States
Nashville, Tennessee 37203, United States
Nashville, Tennessee 37203, United States
Blacksburg, Virginia 24060, United States
Low Moor, Virginia 24457, United States
Roanoke, Virginia 24014, United States
Salem, Virginia 24153, United States
Wytheville, Virginia 24382, United States
Seattle, Washington 98104, United States
Nanjing, Jiangsu 210000, China
Tianjin, Tianjin Municipality 300211, China
Shinjuku-ku, Tokyo 1608582, Japan
Mayagüez, 00680, Puerto Rico